Otsuka, JP3188220002

Otsuka Holdings stock gets a renal therapy update

Published on 10/07/2026 at 04:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS kept a Buy rating and set a JPY 15,000 target on October 2 after uRDN gained Class I reimbursement status. Q2 revenue reached JPY 702.05 billion on July 31.

Otsuka, JP3188220002, Illustration mit AI erstellt.

Otsuka Holdings stock was last at JPY 11,500 on the Tokyo Stock Exchange on October 7, 2026 at 11:30 a.m. JST, up 0.39 percent from the prior close. The central company development is uRDN, whose Class I reimbursement status opens a potential new revenue stream for the Japanese healthcare group.

Renal therapy changes the outlook

According to Futu on October 2, Otsuka said its renal denervation procedure had secured Class I reimbursement eligibility. The report said UBS expects actual reimbursement to begin in January 2028 and estimated potential uRDN revenue of JPY 100 billion to JPY 200 billion after that start date.

UBS maintained a Buy rating and set a 12-month target price of JPY 15,000, according to Futu. Against the October 7 price of JPY 11,500, that target stands 30.43 percent higher, using the same yen-denominated market.

Q2 figures beat the forecast

Otsuka reported Q2 2026 revenue of JPY 702.05 billion and adjusted earnings per share of JPY 222.76 on July 31, according to Investing.com. Revenue exceeded the cited JPY 641.07 billion forecast by 9.51 percent, while EPS was 40.02 percent above the JPY 159.10 estimate.

The figures give the reimbursement story a current earnings base rather than leaving it as a distant pipeline possibility. The principal counter-factor is timing: the uRDN revenue estimate applies after January 2028, so near-term valuation still depends on existing pharmaceutical and nutraceutical operations.

Consensus target stays above the price

Investing.com lists a Strong Buy consensus from 12 analysts, with a JPY 14,933.3 average target, a JPY 11,500 low and a JPY 18,600 high. The average target is 29.85 percent above the October 7 price, leaving the consensus focused on earnings growth and future pipeline value.

Otsuka stock holds near its yearly high

Otsuka Holdings stock was last at JPY 11,500 on October 7, 2026, with a session range of JPY 11,490 to JPY 11,705 and a 52-week range of JPY 7,756 to JPY 12,795. Market capitalization stood at JPY 6.0 trillion and volume reached 310,300 shares.